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DObjective: The study objective was to evaluate long-term trends in morbidity and mortality in a national cohort
of adult patients with a systemic right ventricle due to the atrial switch for transposition of the great arteries or
congenitally corrected transposition of the great arteries.
Methods: We performed a retrospective cohort study from a baseline of 18 years, including life table and
Kaplan–Meier analysis for probability of death/transplant, arrhythmia, surgical or percutaneous intervention,
and permanent pacemaker insertion.
Results: A total of 97 adults with transposition of the great arteries–atrial switch (Mustard procedure in 80/Sen-
ning procedure in 17) and 32 adults with congenitally corrected transposition of the great arteries survived. The
median ages at latest follow-up were 29 and 34 years, respectively. At 40 years of follow-up, freedom from death
or transplant was 0.90 for those with transposition of the great arteries–atrial switch and 0.84 for those with
congenitally corrected transposition of the great arteries (P ¼ .833). Freedom from arrhythmia at 40 years of
follow-up was 0.51 for those with transposition of the great arteries–atrial switch and 0.93 for those with con-
genitally corrected transposition of the great arteries (P ¼ .007). Freedom from intervention at 40 years of
follow-up was 0.33 for those with transposition of the great arteries–atrial switch after initial repair and 0.53
for those with congenitally corrected transposition of the great arteries (P ¼ .938). Freedom from pacemaker
insertion at 40 years of follow-up was 0.77 for those with transposition of the great arteries–atrial switch and
0.62 for those with congenitally corrected transposition of the great arteries (P ¼ .161).
Conclusions: Those patients who survive to adulthood with a systemic right ventricle experience low mortality
and good functional status up to 40 years of age. However, there is a substantial burden of atrial tachyarrhythmia,
and this occurs significantly earlier in those with transposition of the great arteries–atrial switch. Management of
atrial tachyarrhythmia, along with systemic right ventricular dysfunction and systemic atrioventricular valve
regurgitation, is likely to be the major challenge for this group of patients over the next decade. (J Thorac Car-
diovasc Surg 2013;145:1493-503)The morphologic right ventricle (RV) supports the systemic
circulation in those individuals with congenitally corrected
transposition of the great arteries (ccTGA) and those who
have survived atrial switch surgery (the Mustard or Senning
procedure) for complete transposition of the great arteries
(TGA). Although atrial switch is no longer the gold stan-
dard for management of TGA, having been superseded by
the arterial switch operation in the late 1980s, many adult
patients with TGAwill have undergone the older procedure.e Scottish Adult Congenital and Cardiac Service, Golden Jubilee National
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The Journal of Thoracic and CarPatients with either diagnosis are at risk of a host of com-
plications associated with the systemic RV (SRV), includ-
ing premature heart failure, regurgitation through the
systemic atrioventricular (AV) valve, AV nodal block and
a need for permanent pacing, tachyarrhythmia, and sudden
cardiac death.
The long-term history of patients with an SRV still
needs to be clearly defined. Most of the cohort studies
of patients after atrial switch focus on establishing
which of the Mustard and Senning procedures was the
best procedure to use, and the majority provide follow-
up to only 20 years. Patients with ccTGA are the subject
of only a handful of cohort studies. Our aim was to es-
tablish the natural history of the SRV in both conditions
and provide a benchmark to which other treatment ap-
proaches for the SRV (eg, placing the morphologic left
ventricle [LV] in the systemic circulation) can be
compared.
We focused on the group of patients who have survived to
at least the age of 18 years, because although this group of
patients is of great interest to clinicians engaged in provi-
sion of an adult congenital heart disease service, to ourdiovascular Surgery c Volume 145, Number 6 1493
Abbreviations and Acronyms
AV ¼ atrioventricular
ccTGA ¼ congenitally corrected transposition of
the great arteries
LV ¼ left ventricle
MRI ¼ magnetic resonance imaging
PA ¼ pulmonary artery
RV ¼ right ventricle
SRV ¼ systemic right ventricle
TGA ¼ transposition of the great arteries
TR ¼ tricuspid regurgitation
VSD ¼ ventricular septal defect
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Dknowledge there are no studies that assess the prognosis for
these survivors.MATERIALS AND METHODS
We performed a retrospective cohort study, with approval from the
regional research ethics committee. We identified 204 patients with
TGA-atrial switch or ccTGA (excluding those who had undergone
single-ventricle palliation) who had attended the national pediatric or adult
congenital cardiac services for Scotland. From this group of patients, we
focused on the subset of adult patients (aged at least 18 years) who had
an SRV. This resulted in a study population of 129 individuals. Dropout
was due to patient death or transplant before the age of 18 years (31 pa-
tients), conversion to a systemic LV before the age of 18 years (5 patients),
loss of follow-up (16 patients), or age less than 18 years at the time of data
collection (23 patients).
Data were collected and anonymized for each individual from our elec-
tronic database and hospital case notes between January 2011 and 2012.
Patient-specific timelines allowed calculation of survival curves for mortal-
ity, atrial arrhythmia, surgical or catheter intervention, and pacemaker in-
sertion. Follow-up was from the age of 18 years. Patients were censored
at the time of their last clinic review, date of death, date of cardiac trans-
plant, or date of surgery to restore the morphologic LV to the systemic cir-
culation (a Senning–Rastelli or arterial switch operation).
During long-term follow-up, patients underwent regular clinical review
that included establishment of New York Heart Association status and as-
certainment of occurrence of cardiovascular events, such as arrhythmia,
hospital admission, and intervention.
Tachyarrhythmia was defined as any supraventricular or ventricular
tachyarrhythmia captured on ambulatory or 12-lead electrocardiograph re-
cording that was clinically significant (ie, caused symptoms or required
treatment). We excluded cases in which tachyarrhythmia occurred exclu-
sively within 30 days of cardiac surgery. Reintervention was defined as
any cardiac surgical or percutaneous cardiac procedure occurring after
baseline. Pacemaker insertion was defined as any permanent epicardial
or endocardial pacemaker, and included those with cardiac resynchroniza-
tion therapy.
Regular imaging with transthoracic echocardiography and, when no
contraindications existed, cardiac magnetic resonance imaging (MRI)
was performed (Table 1). This was used to establish the degree of tricuspid
regurgitation (TR) and SRV dysfunction. A total of 50 patients underwent
formal cardiopulmonary exercise testing, and peak oxygen uptake (mea-
sured in mL$kg$min1) was recorded if the test was maximal (Table 1).
Since 2010, cardiac MRI and cardiopulmonary exercise test have been per-
formed routinely on both groups of patients regardless of functional status
or presumed need for surgery to clarify anatomy and provide more accurate1494 The Journal of Thoracic and Cardiovascular Surassessment of ventricular function, and we believe the values obtained from
these data provide an accurate cross-sectional assessment of the cohort at
the time of data collection.
Data were described as frequencies, means and standard error, and me-
dians and interquartile range. Means were compared with the independent
samples t test, and medians were compared with the independent samples
median test. Chi-square test using linear-by-linear association was used to
assess the relationship between severity of TR and severity of SRV
impairment.
Cumulative probability of survival was estimated using the Kaplan–Me-
ier and life table method, and differences between groups were evaluated
via the log-rank test. We performed analysis for survival from death or
transplant, atrial tachyarrhythmia, surgical intervention after baseline,
and pacemaker therapy.
Cox proportional hazards models were used to identify predictors for
death or cardiac transplant. All analyses were performed using PASW
Statistics v18.0.3 (IBM corporation, New York, NY).RESULTS
We first identified the 204 patients in the pediatric popu-
lation (Figure 2). Patients were censored at the time of their
last review, when they died, when they received a cardiac
transplant, or when they underwent surgery that restored
the morphologic LV to the systemic circulation and the
RV to the pulmonary circulation (ie, a double switch or Sen-
ning–Rastelli). Although a clear survival advantage up to 10
years was experienced by those with TGA-atrial switch,
mortality between the 2 cohorts was remarkably similar
after this time (log-rank P ¼ .657). Of 133 patients with
TGA-atrial switch (89 male, 44 female), 88 had ongoing
follow-up, 23 died, 19 were lost to follow-up, 2 underwent
cardiac transplantation, and 1 underwent a subsequent arte-
rial switch procedure. Of 71 patients with ccTGA (46 male,
25 female), 49 had ongoing follow-up, 14 died, 3 were lost
to follow-up, 1 underwent cardiac transplantation, 1 under-
went an atrial and arterial double switch operation, and 3
underwent Senning–Rastelli repair.
The red line indicates the period from 18 years of follow-
up and the major area of interest for this study. There were
97 adult survivors of atrial switch surgery for TGA and 32
adult survivors of ccTGA. The characteristics are outlined
in Table 1.
Most of the patients undergoing atrial switch had under-
gone a Mustard repair, with only 17% undergoing the Sen-
ning procedure. More coexistent lesions were present in
those patients with a diagnosis of ccTGA. By the end of
the follow-up period, the majority of patients had good
functional status, normal or only mild impairment of SRV
function, and no or mild TR, with only 2 patients with
ccTGA proceeding to tricuspid valve replacement and
only 3 patients with severe regurgitation.
We assessed the relationship between SRV impairment
and severity of TR. The 2 patients who underwent tricuspid
valve replacement were excluded from the analysis. The
chi-square value for linear-by-linear association between
SRV impairment and severity of TR was 10.064gery c June 2013
TABLE 1. Baseline characteristics, morbidity, and final outcome in
patients with transposition of the great arteries–atrial switch and
congenitally corrected transposition of the great arteries
TGA-atrial
switch ccTGA P value
N 97 32
Male 64 20
Female 33 12
Age (y)
Median (IQR) 29 (25-32) 33 (23-46) .331
Follow-up from 18 y
Median (IQR) 10.8 (6.5-13.9) 13.2 (5.1-28.2) .256
Atrial switch operation
(%)
Mustard 80 (83) N/A
Senning 17 (17) N/A
Coexistent congenital
lesions
Dextrocardia 0 7
VSD 10 20
Pulmonary stenosis 13 11
Pulmonary atresia 0 4
Ebstein 0 1
Coarctation 3 0
Outcome
Ongoing follow-up 86 28
Lost to follow-up 5 1
Died 5 2
Transplant 1 1
Cause of death
Heart failure 1 1
Sudden 3 1
Sepsis 1 0
Tachyarrhythmia
No 72 26
Yes 21 4
Up-to-date imaging (%)
Echocardiography 73 (75) 24 (73)
MRI 22 (22) 5 (16)
SRV impairment
Nil 26 10
Mild 32 13
Moderate 18 5
Severe 6 1
Cardiac MRI
(mean  SE)
SRV EDV 111  8.8 127  18.3 .442
SRV EF% 54  2.3 61  2.6 .190
LVEDV 79  6.0 92  11.0 .337
LVEF% 60  2.6 66  3.3 .220
TR
Nil 42 2
Mild 40 12
Moderate 13 9
Severe 0 3
Replaced 0 2
(Continued)
TABLE 1. Continued
TGA-atrial
switch ccTGA P value
NYHA class
I 65 21
II 20 5
III 1 1
IV 2 1
No. of patients assessed
by CPET (%)
33 (34) 17 (53)
CPET (mean  SE)
VO2 max (mL/kg/min) 25  1.2 25  2.1 .937
VO2 max (% peak
predicted)
68.5  2.8 62.4  4.3 .225
Heart rate reserve
(beats/min)
29  3.7 35  5.9 .374
VE/VCO2 36  1.1 34  1.9 .196
Female patients with at
least 1 successful
pregnancy
7 3
PA band (%) 13 (13) 1 (3)
Median age (IQR) 20.6 (18.0-25.8) 14.2 (N/A)
Median follow-up (y)
post-PAB (IQR)
5.8 (4.3-7.2) 6.4 (N/A)
Median velocity m/s
(IQR)
3.4 (2.3-3.9) 3.3 (N/A)
Median LV:SRV
pressure
0.40 (0.16-0.47) 0.32 (N/A)
Baffle intervention by
type
Surgery 12 operations in 11
patients
N/A
Catheter 20 procedures in 18
patients
N/A
Total* 32 procedures in 26
patients
N/A
Indication for baffle
intervention (%)
Baffle leak 8 (25.0) N/A
Baffle obstruction
SVC limb stenosis 10 (31.3) N/A
IVC limb stenosis 5 (15.6) N/A
PVP stenosis 6 (18.8) N/A
Obstruction not
specified
1 (3.1) N/A
Unknown 1 (3.1) N/A
Pacemaker (%) 17 (18) 13 (41)
CRT (%) 3 (3) 1 (3)
TGA, Transposition of the great arteries; ccTGA, congenitally corrected transposition
of thegreat arteries; IQR, interquartile range;VSD,ventricular septal defect;MRI,mag-
netic resonance imaging; SRV, systemic right ventricle;RV, right ventricle; SE, standard
error; VO2 max, peak oxygen uptake in mL/kg/min; EDV, end-diastolic volume;
EF, ejection fraction; SRVEDV, systemic right ventricle end-diastolic volume; LVEDV,
left ventricle end diastolic volume; LVEF, left ventricular ejection fraction; TR, tricus-
pid regurgitation; NYHA,New York Heart Association; CPET, cardiopulmonary exer-
cise test; VO2, oxygen uptake; VE/VCO2, minute ventilation to carbon dioxide output
ratio; PA, pulmonary artery; PAB, pulmonary artery banding; LV, left ventricle;
SVC, superior vena cava; IVC, inferior vena cava; PVP, pulmonary venous pathway;
CRT, cardiac resynchronization therapy; N/A, not available. *Six patients had 2 inter-
ventions each, with a total of 26 individual patients undergoing at least 1 intervention.
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FIGURE 1. Coexistent lesions and initial surgery in 32 patients with ccTGA. ccTGA, Congenitally corrected transposition of the great arteries; VSD, ven-
tricular septal defect; LVOTO, left ventricular outflow tract obstruction; LV, left ventricle; PA, pulmonary artery; TVR, tricuspid valve replacement.
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between the 2 variables.
More detailed assessment of ventricular function and
functional capacity was performed by means of cardiac
MRI and cardiopulmonary exercise testing, because this isFIGURE 2. Long-term survival in 133 patients after atrial switch surgery
for TGA and 71 patients with ccTGA. The red line indicates the period
from 18 years of follow-up, and the major area of interest for this study.
ccTGA, Congenitally corrected transposition of the great arteries.
1496 The Journal of Thoracic and Cardiovascular Sura routine form of evaluation for all eligible patients at this
center with an SRV, regardless of clinical status. From car-
diac MRI in 27 patients, the mean ejection fraction of the
SRV was lower in those with TGA-atrial switch than in
those with ccTGA (54% vs 61%), although this was not
significant. There was no clear relationship between time
from baseline and ventricular volumes or ejection fraction.
Mean peak oxygen uptake for 50 patients in both groups
was 25 mL/kg/min. There was no statistically significant
difference in peak oxygen uptake, heart rate reserve, and
minute ventilation to carbon dioxide output ratio between
the 2 cohorts.
Intervention was common. Baffle problems accounted
for most of this in the atrial switch group, with 26 patients
(26.8% of the adult TGA-atrial switch cohort) requiring
further intervention. Of this group of patients, 24 (of a pos-
sible 80) had undergone a Mustard repair, compared with 2
patients undergoing a Senning (of a possible 17). The ma-
jority of intervention was performed percutaneously, and
baffle obstruction was a more frequent indication for inter-
vention than a leak. In the majority of cases, the initial in-
tervention was successful at treating the baffle leak or
stenosis, with only 6 patients (Mustard in 5, Senning in 1)
requiring more than 1 repeat intervention. In 2 patients
(Senning repair), partially successful percutaneous inter-
vention for a baffle leak was followed by definitive surgical
treatment 2 years later. One patient (who underwent a Mus-
tard repair) required 2 surgical baffle repairs, albeit 14 years
apart, for obstruction of the pulmonary venous pathway.
Two patients each required 2 attempts at cathetergery c June 2013
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neous intervention after initial surgical revision of the
baffles.
A total of 13 of 97 patients with TGA-atrial switch under-
went subsequent pulmonary artery (PA) banding for treat-
ment of SRV dysfunction, 1 of whom later died suddenly
3 years post-banding (presumed arrhythmic in cause). Up-
to-date imaging was not available for 1 other patient who
underwent this procedure. For the remaining 11 patients,
the median follow-up period was 5.8 years. The mean gra-
dient through the PA band was 3.4 m/s. SRV function was
normal or mildly impaired in 9 patients, moderately im-
paired in 1 patient, and severely impaired in 1 patient. There
was no or mild systemic TR in 6 of 11 patients, with 4 pa-
tients having moderate regurgitation and 1 patient having
severe regurgitation. None of the patients with PA banding
were ever deemed suitable for a subsequent double-switch.
Other indications for reintervention in the TGA-atrial
switch group were enlargement of the subpulmonary LV
outflow tract, repair of aortic coarctation, and cardiac trans-
plant. No TGA-atrial switch cases have yet been referred for
tricuspid valve replacement.
In the ccTGA group, most intervention was directed at
correction of underlying anatomic lesions, such as a ventric-
ular septal defect (VSD) (Figure 1), although 1 patient with
preexisting left ventricular outflow tract obstruction and
a VSD required PA banding for a failing SRV, and 1 patient
required tricuspid valve replacement. Both patients were
doing well at their most recent follow-up. Although a num-
ber of pediatric patients have ultimately undergone a double
switch or Senning–Rastelli, none of the adult survivors
have.
Cumulative survival from each adverse outcome for the
129 patients who reached the age of 18 years is outlined
in detail in Figure 3. The dropoff at baseline (age 18 years)
reflects the number of adverse events that had occurred in
individuals before the age of 18 years.
There was no significant difference in survival between
patients with TGA-atrial switch and patients with ccTGA
(log-rank test P ¼ .833). Cumulative survival (including
cardiac transplantation) was 0.99  0.01, 0.90  0.04,
and 0.90  0.04 at 20, 30, and 40 years post-atrial switch,
respectively, and 0.97  0.03, 0.91  0.06, and 0.84 
0.09 at 20, 30, and 40 years post-ccTGA, respectively. Al-
though there seemed to be an abrupt decrease in survival
to approximately 0.40 at more than 45 years from baseline
for the TGA-atrial switch cohort, only 2 patients had been
followed for this length of time; therefore, this value was
not thought to be sufficiently representative of thewhole co-
hort. There was no significant difference in survival from 18
years of follow-up between Mustard and Senning cases
(log-rank test P ¼ .625), although after 27 years of
follow-up graphic trends favored those undergoing the Sen-
ning. There was no significant difference between simpleThe Journal of Thoracic and Carand complex TGA-atrial switch (P ¼ .562). There was no
significant difference in survival between simple and com-
plex ccTGA after 18 years of follow-up (log-rank test
P ¼ .662). There was no significant difference in survival
between the 14 patients in both groups who underwent PA
banding and those who did not (P ¼ .659). A univariate
analysis with a Cox proportional hazards model was per-
formed to establish risk factors for death or transplant
(Table 2). Severe SRV impairment at baseline was most
strongly associated with risk of death or transplant, albeit
with wide confidence intervals.
Patients with ccTGA demonstrate low arrhythmia burden
with cumulative survival from tachyarrhythmia of 1.00,
1.00, and 0.93  0.07 at 20, 30, and 40 years, respectively.
This was significantly better than in those who received
atrial switch, who experienced survival of 0.91  0.03,
0.73 0.06, and 0.54 0.14 at 20, 30, and 40 years, respec-
tively (log-rank test ¼ 0.007). All documented tachyar-
rhythmias were supraventricular: There were no instances
of documented ventricular tachycardia causing symptoms
or requiring treatment (although the sudden deaths that
occurred may have been due to this).
Freedom from intervention at 20, 30, and 40 years of
follow-up was 0.74  0.05, 0.57  0.06, and 0.33  0.08
for TGA-atrial switch, respectively, and 0.57  0.09, 0.53
 0.10, and 0.53  0.10 for ccTGA, respectively (log-rank
test P ¼ .938).
There was no significant difference between the 2 groups
for cumulative survival from pacemaker insertion (log-rank
test P¼ .161), although graphic trends favor the TGA-atrial
switch group. Freedom from pacemaker insertion at 20, 30,
and 40 years of follow-up was 0.87 0.04, 0.82 0.04, and
0.77 0.06 for TGA-atrial switch, respectively, and 0.79
0.08, 0.69 0.09, and 0.62 0.11 for ccTGA, respectively.
DISCUSSION
Mortality
Overall mortality to 40 years is low in both cohorts, with
the cumulative probability of survival estimated at 90%
survival after atrial switch and 84% after ccTGA. Of the
7 deaths after 18 years of follow-up, 4 were sudden and 2
were secondary to heart failure (1 patient with ccTGA
died after referral for cardiac transplant assessment). This
is similar to other studies. Sudden death and heart failure ac-
counted for the majority of late deaths in 2 large retrospec-
tive studies of a combined total of approximately 700
atrial switch cases1,2 and in a large retrospective study of
survivors of surgery for ccTGA.3 Therefore, strategies to
identify those at risk of sudden cardiac death and to manage
systemic RV dysfunction will be crucial to improve out-
comes in these patients.
Direct comparison between our cohort of adult survivors
and the larger cohort studies of SRV is difficult because
most studies include early postoperative and pediatricdiovascular Surgery c Volume 145, Number 6 1497
FIGURE3. Mortality andmorbidity in 129 adult survivors of ccTGA and atrial switch surgery for TGA. ccTGA,Congenitally corrected transposition of the
great arteries.
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this cumulative mortality was broadly similar (Table 3). It
remains to be seen whether the adaptation of an early ag-
gressive strategy for patients with ccTGA, by which the
morphologic LV is connected to the systemic circulation,
results in improved survival into adulthood. However,
Brawn4 reports survival of 90% at up to 9 years in a cohort
of 56 patients with ccTGA who underwent both types of
double switch (atrial and arterial switch, and Senning–Ras-
telli), with an early mortality of 5.6%.4 Ly and colleagues51498 The Journal of Thoracic and Cardiovascular Surreported 100% survival at 60 months in 20 patients with
complex ccTGAwho underwent the Senning–Rastelli pro-
cedure. Shin’oka and colleagues6 reported 74.5% survival
at 15 years in 15 patients undergoing atrial-arterial switch
and 80% survival at 16 years in 69 patients undergoing
the Senning–Rastelli procedure. Poorer survival was re-
ported in the Senning–Rastelli group compared with the
atrial-arterial switch group in another study with data up
to 10 years of 65 patients undergoing anatomic repair.7
However, this is in contrast to a 2006 meta-analysis ofgery c June 2013
TABLE 2. Hazard ratios for death or cardiac transplant in adult
survivors with a systemic right ventricle
Variable HR P value 95% CI
Male 2.286 .303 0.474-11.033
Initial VSD 2.370 .208 0.619-9.081
Initial BT shunt 1.537 .692 0.183-12.89
Tachyarrhythmia 0.046 .717 0-N
Pacemaker 2.349 .290 0.483-11.417
Severe TR (or valve replacement) 3.064 .305 0.360-26.072
Severe SRV impairment 12.092 .002 2.424-60.309
PA band 1.606 .662 0.191-13.484
HR, Hazard ratio; CI, confidence interval; VSD, ventricular septal defect; BT, Bla-
lock–Taussig; TR, tricuspid regurgitation; SRV, systemic right ventricle.
Dobson et al Congenital Heart Disease
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which the Senning–Rastelli procedure conferred a survival
benefit at least for in-hospital mortality; however, there
were no data regarding longer-term outcomes.8 Although
these results are clearly encouraging, the prognosis to adult-
hood and beyond remains to be established.Morbidity
Tachyarrhythmia. Atrial tachyarrhythmia was common
in patients with an SRV. However, it occurred significantly
earlier in survivors of atrial switch surgery (P¼ .007). This
may be due to the extensive atrial scar tissue and potential
for macro-reentry circuits. The relatively high prevalence
of arrhythmia in both cohorts at 40 years is cause for con-
cern, because its management is extremely challenging
even for experienced electrophysiologic physicians.
Systemic right ventricle impairment and tricuspid
regurgitation. At the time this study was performed, the
majority of patients in both cohorts exhibited insignificant
or mild SRV impairment and TR. However, severe SRV im-
pairment was a significant risk factor for death, and man-
agement is controversial. We confirmed a clear correlationTABLE 3. Reported long-term survival for 1282 patients after atrial switch
the great arteries
Author Population
TGA-atrial switch
Dobson et al Mustard and Senning (pediatric data)
Lange et al1 Mustard only
Moons et al2 Mustard and Senning
Sarkar et al30 Mustard and Senning
Wilson et al31 Mustard only
ccTGA
Dobson et al ccTGA (operated and unoperated)
Lim et al3 ccTGA (123 physiologic and 44 anatomic repair)
Hraska et al32 ccTGA (operated and unoperated)
Yeh et al33 ccTGA (physiologic and 9 anatomic repair)
TGA, Transposition of the great arteries; ccTGA, congenitally corrected transposition of th
The Journal of Thoracic and Carbetween severity of SRV impairment and severity of TR,
in keeping with the published literature.9,10 Cardiac MRI
data suggested that overall mean SRV function for the
group was good in ccTGA cases, with an SRV ejection
fraction of 61%, and only mildly impaired in atrial switch
cases, with an SRV ejection fraction of 54% (P ¼ .190).
Of note, mean SRV end-diastolic volume was slightly
higher in the ccTGA cases; however, the difference was
not statistically significant.
Approaches tomanagement of SRV failure are controver-
sial. Early intervention for a regurgitant systemic tricuspid
valve has been advocated in view of its correlation with
SRV failure. However, results are poor in patients who
have preexisting SRV impairment; therefore, this is a pro-
phylactic strategy rather than an option for patients who al-
ready have a failing SRV. Furthermore, long-term
prognostic data are lacking, and there are no large-scale
case-control studies.10-12 Generally, tricuspid valve
replacement rather than repair is advocated if the RV is
planned to remain in the systemic circulation.10,13
The atrial-arterial double switch or Senning–Rastelli pro-
cedures, if performed early enough in a center with suffi-
cient expertise, eliminate the problem of SRV dysfunction
and TR. However, results are unfavorable in adult pa-
tients.4,14,15 Furthermore, there is a risk of a range of new
complications, including dysfunction of the newly
systemic LV and insufficiency through the neoaortic valve
(in the case of atrial-arterial double switch).4
The process of training the LV through the placement of
a PA band is used as a treatment in its own right, because
higher LV pressures avoid septal dyskinesis exacerbating
SRV impairment, and in theory helps to prevent tricuspid
annular dilatation, thus lessening the severity of TR. In
the small subcohort of our group of patients undergoing
PA banding, most maintained normal or only mildly im-
paired SRV function. However, there was no overallsurgery and 488 patients with congenitally corrected transposition of
Year N
Cumulative probability of death
10 y 20 y 30 y 40 y
2012 133 0.96 0.83 0.78 0.68
2006 395 0.86 at 25 y
2004 283 0.92 0.87 0.79
1999 358 0.82*
0.94y
1998 113 0.90 0.80
2012 71 0.87 0.79 0.77 0.67
2010 167 0.8 0.83
2005 123 0.72 0.59
1999 127 0.80 0.66
e great arteries. *Mustard. ySenning.
diovascular Surgery c Volume 145, Number 6 1499
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existed. This is confirmed by 2 relatively large studies of
39 and 20 patients,16,17 respectively, although some older,
smaller trials suggest a modest beneficial effect on
TR.13,18,19 The biggest problem with PA banding seems to
be the development of dysfunction of the subpulmonary
LV.16,19
There is only modest evidence for the efficacy of cardiac
resynchronization therapy, and again the main problem
seems to be the development of LV dysfunction.20,21
Cardiac transplantation is effective; however, there is the
problem of limited donor organ availability in many parts
of the world and the additional risk conferred by the
complexity of abnormal anatomy and previous surgical
intervention.
Functional Data
In keeping with the other cohort studies described previ-
ously, patients with atrial switch and patients with ccTGA
continue to enjoy good functional status. Approximately
98% of patients with atrial switch for whom data were
available (85/87) and 93% of patients with ccTGA (26/
28) were in New York Heart Association class I or II. Me-
dian follow-up was to 29 and 33 years of age, respectively.
Formal cardiopulmonary exercise testing demonstrated
reduced maximum oxygen uptake compared with peak pre-
dicted, with a mean peak oxygen uptake of 25 mL/kg/min
for both atrial switch and ccTGA cases. This is in keeping
with previous studies assessing exercise performance in pa-
tients with an SRV.22,23 We also demonstrated evidence of
an abnormally high heart rate reserve and increased
minute ventilation to carbon dioxide output ratio, again in
keeping with previous work.24-26
Reintervention
There was relatively high attrition in both cohorts, with
cumulative probability of freedom from reintervention of
57% in atrial switch cases and 53% in ccTGA cases at
30 years.
In the TGA-atrial switch cohort, the relatively high rate
of baffle reintervention may be explained by the fact that
most patients had undergone aMustard repair, and this tech-
nique was associated with a higher incidence of baffle
obstruction than the Senning repair in an earlier meta-anal-
ysis.27 There was only 1 cardiac transplant. There have been
no systemic AV valve replacements. Although 1 arterial
switch procedure was performed in a patient who had pre-
viously undergone atrial switch, this was performed at the
age of 8 years, and therefore before at least 18 years of
follow-up had elapsed.
In the ccTGA cohort, physiologic repair of coexistent
cardiac lesions accounted for most intervention. Most sur-
gery was performed during childhood, with intervention
after 18 years far less common than intervention before1500 The Journal of Thoracic and Cardiovascular Sur18 years. The only surgery performed after 18 years of
age was 1 tricuspid valve replacement and 1 late physio-
logic repair involving VSD closure and relief of left ventric-
ular outflow tract obstruction via pulmonary valvotomy.
Systemic AV (tricuspid) valve replacement in patients
with an SRV is controversial. Some centers advocate early
replacement of an incompetent systemic AV valve because
of the relationship between SRV impairment and systemic
atrioventricular valve regurgitation. A double switch strat-
egy, with a subsequent arterial switch operation, also is
controversial.28
Pacemaker Therapy
There was no significant difference between the 2 cohorts
for survival from pacemaker insertion, and this was a partic-
ularly common problem in the ccTGA cohort. Use of car-
diac resynchronization therapy was low, presumably
reflecting the lack of evidence to support its use. Of note,
there were no automatic implantable cardioverter defibrilla-
tor insertions. Although there is a high risk of sudden car-
diac death, there are no established guidelines for formal
risk assessment, and automatic implantable cardioverter de-
fibrillator insertion in patients with an SRV is based on
a ‘‘common sense’’ approach extrapolated from studies in
other populations.29
Study Limitations
As with all retrospective studies, our study is limited by
those patients lost to follow-up both before and after the
age of 18 years, although these numbers were relatively
small. Another group of patients missing from the analysis
are those with asymptomatic uncomplicated ccTGA, who
have yet to present to medical services or are not recognized
as having cardiac anatomy consistent with ccTGA. How-
ever, on the basis of our own experience, few patients
with ccTGA present after the age of 18 years. Furthermore,
all longitudinal cohort studies of ccTGAwill have the same
problem.
Functional data regarding ventricular function as as-
sessed by cardiac MRI are lacking for a relatively large
number of patients, and in many cases this is unavoidable
because of the presence of a cardiac rhythm device. Further-
more, our service has yet to fully assess the cohort of pa-
tients with SRV by means of a cardiopulmonary exercise
test, and the sickest patients are typically too unwell to al-
low determination of peak exercise capacity by this method.
CONCLUSIONS
Overall mortality is low at up to 40 years of follow-up in
adult survivors of atrial switch surgery for TGA or ccTGA.
Furthermore, mortality is remarkably similar between the 2
cohorts. This suggests that for the majority of patients, it is
actually the SRV itself, rather than the nature of any prior
surgery, that determines true long-term prognosis. SRVgery c June 2013
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plant, and most deaths are sudden or due to heart failure.
Morbidity is substantial, with a high incidence of tachy-
arrhythmia, surgical or catheter intervention, and pace-
maker insertion. Tachyarrhythmia is a particular problem
for TGA-atrial switch cases because it occurs significantly
earlier than in ccTGA cases. However, moderate to severe
SRV dysfunction, TR, and functional impairment are rela-
tively rare up to 40 years. Risk stratification for sudden car-
diac death and the identification of suitable strategies to
manage SRV impairment will be key to improving survival
in the future. In view of the high burden of SRV impairment,
an early aggressive strategy aimed at anatomic repair may
be warranted in the patients with ccTGA who require cor-
rective surgery for coexistent lesions. For the asymptomatic
patient with uncomplicated ccTGA, there is insufficient
adult follow-up data to comment on whether an anatomic
repair strategy is better than conservative management.
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Dr Shunji Sano (Okayama, Japan). There is always debate on
whether the morphologic RV supports the systemic circulation for
the patient’s entire life or not. The American College ofdiovascular Surgery c Volume 145, Number 6 1501
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DCardiology/American Heart Association guidelines show that ven-
tricular dysfunction seems to be related to systemic AV valve re-
gurgitation. In the absence of associated congenital anomalies,
primary RV failure is uncommon. Abnormality of the systemic
AV valve is Ebstein-like malformation in 90% of the patients. In
your series in the adult group, only 4 patients had Ebstein’s.
From your data, mortality is low with survival of 90% for
TGA-atrial switch and 84% for ccTGA. However, cumulative
mortality at 40 years from birth is 68% for TGA-atrial switch
and 67% for ccTGA. This means most of the deaths in these pa-
tients occur in the pediatric age, and in the patients who survived
to adult age, mortality is low with good RV function.
Do you have any data of TR and RV impairment of ccTGA in
the pediatric age population, and what was the reason of death
of these patients after TGA-atrial switch and ccTGA in the pediat-
ric age population?
Dr Dobson. The main aim of this study was to look at outcomes
in the adult patients who were cared for by the adult congenital
heart disease service. In terms of causes of death in the pediatric
population, we didn’t assess this in detail. Furthermore, I have lim-
ited data regarding the severity of TR and systemic RV impairment
as estimated from echocardiography or MRI in patients before the
age of 18 years.
However, one can make some deductions. A significant number
of the pediatric deaths occurred in association with the initial re-
pair and early postoperative course, and most of these were in
the late 1970s or early 1980s. SRV failure also was a significant
problem: Five patients in the pediatric population subsequently
went on to have a successful double switch procedure, and 1 pa-
tient required cardiac transplantation after unsuccessful PA band-
ing. The other cause of mortality in the pediatric patients was
sudden cardiac death. This raises the question of how to prevent
deaths due to SRV failure.
We know that as patients become older it is difficult to train the
morphologic LV in preparation for an anatomic repair. Therefore,
patients should be prepared for this at a young age, really as soon
as it has become evident that they have significant TR or signifi-
cant SRV failure. Professor Vouhe in Paris has published some fas-
cinating work on applying a prophylactic PA band to all patients
from birth with ccTGA. The reason behind this is to maintain
physiologic training of the LVand, in theory, to be able to offer an-
atomic repair to all patients with ccTGA should they require it.
The key role of any research in this group is to try and identify
a strategy that promptly identifies and intervenes in those patients
at high risk of SRV failure, while at the same time recognizing that
there are other patients who will do well with a more conservative
approach.
Dr Sano. Your freedom from arrhythmia at 40 years was 0.51
for TGA-atrial switch and 0.93 for ccTGA. There is a discrepancy
between TGA-atrial switch and ccTGA. Most of the arrhythmia in
those with TGA-atrial switch was atrial tachyarrhythmia, and most
of your atrial switch procedures were Mustard. Therefore, the rea-
son of the arrhythmia is due to late complication of Mustard rather
than RV dysfunction. Is the rate of arrhythmia the same in the Sen-
ning and Mustard groups?
Dr Dobson. The key thing is that the Senning group was
smaller. I don’t have the exact figures at hand, but I will find it
for you later. If one looks at the absolute values, certainly Mustard1502 The Journal of Thoracic and Cardiovascular Surcases accounted for most of the burden of tachyarrhythmia in the
TGA-atrial switch cohort. Of the 21 patients in the atrial switch co-
hort with documented tachyarrhythmia, only 2 underwent Senning
repair; the rest underwent Mustard. However, the a smaller number
of patients underwent Senning, accounting for only one fifth of the
atrial switch cases, and subsequent analysis demonstrated that
there was no statistically significant difference in freedom from
tachyarrhythmia between the 2 groups, with a P value of .892 as
estimated by the log-rank test: this data set is therefore underpow-
ered in this respect.
However, when one compares freedom from tachyarrhythmia
between the TGA-atrial switch cohort and the ccTGA cohort
you are absolutely correct, there were higher rates of arrhythmia
in TGA-atrial switch cases compared with ccTGA cases. My
own feeling is that this reflects the extensive atrial scar tissue
that has occurred as a result of the initial surgery, leading to a pro-
pensity for atrial macro-reentrant tachycardia.
Dr Sano. So that means if you perform a Senning operation,
most of these arrhythmias will be avoided. Recent reports from
many centers show a 20-year survival of more than 70% to 80%
after the double switch, and the Fontan operation is now adopted
in many cases rather than complex intracardiac repair, with a 10-
to 20-year survival of 70% to 90%, and the reintervention after
Fontan is low.
We recently reported our results of ccTGA. Although the mean
follow-up is only 10 years, in a double switch with the Senning ar-
terial switch group, there was no mortality. In the Senning–Rastelli
group, wemeasured the length between interventricular septum and
aorta, and all early and late mortality came from the group with
a long distance between the interventricular septumand aorta. There
was no mortality in the patients with the short distance. Therefore,
we do a Fontan operation in the long distance group and a double
switch in the short distance group. I hope the long-term survival
will improve using different techniques in individual patients.
Dr John Foker (Minneapolis, Minn). This is a valuable study,
because there are a number of these patients. I did 50 atrial baffle
procedures (modified Shumacker) for simple transposition. They
all left the hospital, 2 or 3 died later suddenly, but many of them
are doing well, including 1 woman who recently gave birth to
a child with TGA.
My question concerns the RV dysfunction. These patients un-
derwent operation at a time when myocardial protection was rudi-
mentary at best and was, in essence, clamp and go, with the RVout
under the hot lights. Do you think the RV dysfunction, when you
see it, could be due mostly to this poor myocardial protection
rather than any intrinsic inability of the RV to serve as the systemic
ventricle? If so, when you looked at these hearts, would you see
subendocardial fibrosis in those that were failing?
Dr Dobson. One would expect that more primitive myocardial
protection techniques would result in greater myocyte necrosis in
the SRV and consequent impairment. However, it is uncertain
whether this is permanent or there is potential for recovery. There
are clearly many other factors that could contribute to the develop-
ment of SRV failure, not least because we know that some patients
with isolated ccTGAwho have never proceeded to surgery some-
times develop significant cardiac failure. To answer your question,
one would need a larger study population. One could then compare
outcomes between patients who had been repaired in the currentgery c June 2013
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Dera with all the advantages of modern techniques of myocardial
protection and patients who had been repaired 20 or 30 years
ago when such technology was less advanced. Multivariate analy-
sis would then allow adjustment for confounding variables and
provide insight into the effect of cardiopulmonary bypass in pre-
dicting those who will go on to develop late systemic RV
impairment.
In answer to the second part of your question, subendocardial
fibrosis is something that is currently difficult to assess by MRI.
Even with late gadolinium enhancement, you are unlikely to be
able to distinguish whether someone definitely has fibrosis. There
is some interesting work looking at the use of MRI edema se-
quences for this purpose. It would be a fascinating study to try
and objectively assess the amounts of fibrosis in SRVs and then
compare these with the era of surgical repair. But I don’t have
the data for that in this study. The other problem is that many of
these patients require permanent pacing, which precludes assess-
ment by MRI at least in the current era.
Dr Gerhard Ziemer (Chicago, Ill). I understand that you have
to simplify your conclusions in a talk like this, but I have to make 2
remarks.The Journal of Thoracic and CarFor atrial repair of TGA, you cannot really put patients with
and without VSD into 1 group and give them a single incidence
for arrhythmias. The same is true for RV function, because you
may have a different cause of RV function impairment, either
secondary to TR or preceding it. This relates to VSD closure
or no VSD closure. So at least in your article you should
discuss this.
My second point relates to you just comparing arrhythmia in-
cidence for ccTGA with arrhythmias in normal transposition.
But you only can compare them for their types of arrhythmias:
Patients post–atrial switch for TGA mainly have atrial arrhyth-
mias and patients post-ccTGA have sudden AV block with
and without surgery. So there is really a different mechanism
of late failure, but I understand the simplification in your
presentation.
Dr Dobson. Thank you.
Dr Craig Smith (New York, NY). This study is a sobering re-
minder that when we are dealing with a population with such
a long life expectancy, the duration of follow-up required to answer
any of these questions is long, and I look forward to the 40-year
follow-up.diovascular Surgery c Volume 145, Number 6 1503
